Abstract
The relationship between serum and saliva chloramphenicol (CAP) concentrations was evaluated in 27 paired specimens collected from 20 hospitalized patients during therapy with the drug. A significant (R = 0.80, P < 0.001) but variable relationship was found to exist. Serum protein binding of CAP was also evaluated (43.7 ± 5.7% bound; N = 24). Differences in CAP binding did not apparently account for a significant portion of the variability in the observed saliva/serum CAP concentration ratios. The degree of variation observed indicated that saliva CAP concentrations could not be relied upon for the prediction of serum CAP concentrations.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BENDER I. B., PRESSMAN R. S., TASHMAN S. G. Studies on excretion of antibiotics in human saliva. II. Chloramphenicol. J Dent Res. 1953 Apr;32(2):287–293. doi: 10.1177/00220345530320021801. [DOI] [PubMed] [Google Scholar]
- BURNS L. E., HODGMAN J. E., CASS A. B. Fatal circulatory collapse in premature infants receiving chloramphenicol. N Engl J Med. 1959 Dec 24;261:1318–1321. doi: 10.1056/NEJM195912242612604. [DOI] [PubMed] [Google Scholar]
- Barkin R. M., Greer C. C., Schumacher C. J., McIntosh K. Haemophilus influenzae meningitis: an evolving therapeutic regimen. Am J Dis Child. 1976 Dec;130(12):1318–1321. doi: 10.1001/archpedi.1976.02120130024004. [DOI] [PubMed] [Google Scholar]
- Cook C. E., Amerson E., Poole W. K., Lesser P., O'Tuama L. Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay. Clin Pharmacol Ther. 1975 Dec;18(6):742–747. doi: 10.1002/cpt1975186742. [DOI] [PubMed] [Google Scholar]
- Craft A. W., Brocklebank J. T., Hey E. N., Jackson R. H. The 'grey toddler'. Chloramphenicol toxicity. Arch Dis Child. 1974 Mar;49(3):235–237. doi: 10.1136/adc.49.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danhof M., Breimer D. D. Therapeutic drug monitoring in saliva. Clin Pharmacokinet. 1978 Jan-Feb;3(1):39–57. doi: 10.2165/00003088-197803010-00003. [DOI] [PubMed] [Google Scholar]
- Eney R. D., Goldstein E. O. Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. Pediatrics. 1976 Apr;57(4):513–517. [PubMed] [Google Scholar]
- Finegold S. M. Therapy for infections due to anaerobic bacteria: an overview. J Infect Dis. 1977 Mar;135 (Suppl):S25–S29. doi: 10.1093/infdis/135.supplement.s25. [DOI] [PubMed] [Google Scholar]
- Grafnetterová J., Vodrázka Z., Jandová D., Schück O., Tomásek R., Lachmanová J. The binding of chloramphenicol to serum proteins in patients with chronic renal insufficiency. Clin Nephrol. 1976 Oct;6(4):448–450. [PubMed] [Google Scholar]
- Hendeles L., Burkey S., Bighley L., Richardson R. Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease. J Allergy Clin Immunol. 1977 Dec;60(6):335–338. doi: 10.1016/0091-6749(77)90063-x. [DOI] [PubMed] [Google Scholar]
- Horning M. G., Brown L., Nowlin J., Lertratanangkoon K., Kellaway P., Zion T. E. Use of saliva in therapeutic drug monitoring. Clin Chem. 1977 Feb;23(2 Pt 1):157–164. [PubMed] [Google Scholar]
- Koup J. R., Brodsky B., Lau A., Beam T. R., Jr High-performance liquid chromatographic assay of chloramphenicol in serum. Antimicrob Agents Chemother. 1978 Sep;14(3):439–443. doi: 10.1128/aac.14.3.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koysooko R., Ellis E. F., Levy G. Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther. 1974 May;15(5):454–460. doi: 10.1002/cpt1974155454. [DOI] [PubMed] [Google Scholar]
- LISCHNER H., SELIGMAN S. J., KRAMMER A., PARMELEE A. H., Jr An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol. J Pediatr. 1961 Jul;59:21–34. doi: 10.1016/s0022-3476(61)80205-9. [DOI] [PubMed] [Google Scholar]
- Levine P. H., Regelson W., Holland J. F. Chloramphenicol-associated encephalopathy. Clin Pharmacol Ther. 1970 Mar-Apr;11(2):194–199. doi: 10.1002/cpt1970112194. [DOI] [PubMed] [Google Scholar]
- Mandel I. D. Relation of saliva and plaque to caries. J Dent Res. 1974 Mar-Apr;53(2):246–266. doi: 10.1177/00220345740530021201. [DOI] [PubMed] [Google Scholar]
- SCOTT J. L., FINEGOLD S. M., BELKIN G. A., LAWRENCE J. S. A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL. N Engl J Med. 1965 Jun 3;272:1137–1142. doi: 10.1056/NEJM196506032722201. [DOI] [PubMed] [Google Scholar]
- SMICK K. M., CONDIT P. K., PROCTOR R. L., SUTCHER V. FATAL APLASTIC ANEMIA. AN EPIDEMIOLOGICAL STUDY OF ITS RELATIONSHIP TO THE DRUG CHLORAMPHENICOL. J Chronic Dis. 1964 Oct;17:899–914. doi: 10.1016/0021-9681(64)90161-4. [DOI] [PubMed] [Google Scholar]
- SUTHERLAND J. M. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. AMA J Dis Child. 1959 Jun;97(6):761–767. doi: 10.1001/archpedi.1959.02070010763001. [DOI] [PubMed] [Google Scholar]
- Sawchuk R. J., Zaske D. E. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. J Pharmacokinet Biopharm. 1976 Apr;4(2):183–195. doi: 10.1007/BF01086153. [DOI] [PubMed] [Google Scholar]
- Thompson W. L., Anderson S. E., Lipsky J. J., Lietman P. S. Letter: Overdoses of chloramphenicol. JAMA. 1975 Oct 13;234(2):149–150. [PubMed] [Google Scholar]
- WEISS C. F., GLAZKO A. J., WESTON J. K. Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses. N Engl J Med. 1960 Apr 21;262:787–794. doi: 10.1056/NEJM196004212621601. [DOI] [PubMed] [Google Scholar]
